. . . . . . . . . . . . . . . "cat(p(HGNC:MAN2A1)) -| p(HGNC:CD40LG)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Reduction in the expression of N-linked oligosaccharides, including L-PHA reactive oligosaccharides, on the cell surface by SW treatment resulted in enhancement of HBL-2 cell survival by CD40L stimulation" . . "Selventa" . . . . "2014-07-03T14:30:22.439+02:00"^^ . . .